US 12,703,344

Application 18/632,768 · Granted Aug 11, 2026

Electrical converter in a hybrid vehicle indicating intermittent cylinder operation

Estimated expiration

November 27, 2042

16y 9d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTEP2022078597: Resource not found (404)
Earliest effective filing
Oct 14, 2022
+ 20 years
Oct 14, 2042
PTA +44d
Nov 27, 2042
No TD
—
Final
Nov 27, 2042

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
April 11, 2024
Earliest effective filing
October 14, 2022
Issue date
August 11, 2026
PTA
+44 days
Base expiry (before PTA)
October 14, 2042

October 14, 2022 + 20 years = October 14, 2042 + 44 PTA days = November 27, 2042

  • Continuation of application PCTEP2022078597, filed Oct 14, 2022

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 18/632,768 · US 12,703,344

PatentReply compiles the prosecution history behind US 12,703,344: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US12703344

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.